Navigation Links
Optimizing the Use of Health Outcomes Data in the Marketplace

CHAPEL HILL, N.C., Sept. 21, 2011 /PRNewswire/ -- Pharmaceutical and biotechnology organizations use health outcomes data to support a variety of product-related initiatives, from treatment guidelines to formulary decisions. With health outcomes data playing such a pivotal role in a product's performance, it's important for organizations to optimize the use of Health Outcomes data.

To help organizations understand current approaches to effectively using health outcomes data in the marketplace, Best Practices, LLC has published a study that examines the internal and external uses of Health Outcomes data for promotional and strategic purposes.

The study, Best Practices in Utilizing Health Outcomes Data, provides comparative data from 2009 and 2011 that illustrate shifting attitudes for how organizations utilize health outcomes data.

Organizations in 2011 used health outcomes data internally mostly for determining market access and scientific publication strategies. Relative to 2009, the importance of using health outcomes data internally for reimbursement decisions increased 24 percent, from 45 percent in 2009 to 69 percent in 2011, according to the study. Meanwhile, in 2011 and 2009, reimbursement and drug formulary decisions were the main use of health outcomes data for interactions with managed care, according to the study.

The 51-page study reflects current approaches to health outcomes data utilization at 16 biopharma organizations; the 2009 data is based on a benchmark class of 29 companies.

The insights in this new study will help pharmaceutical and biotech organizations compare their use of health outcomes data in promotional and internal settings with that of leading organizations. The study also examines the pressing regulatory issues raised by the different uses of health outcomes data.

Key topics covered in this research include:

  • Structure and Reporting Lines of Authority
  • Use of Health Outcomes Data Proactively and Retrospectively
  • How Health Outcomes Data is Utilized within Different Groups
  • Health Outcomes Review Process and Structure
  • Best Practices in Health Outcomes Utilization

To download a complimentary study excerpt, go to:


Best Practices, LLC is a research and consulting firm that has served many of the world's 50 top pharmaceutical companies.  For more than 17 years, we have conducted work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.  For more information about the company, go to

SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Prometheus and the Medco Research Institute® to Evaluate the Use of Prometheus Thiopurine Metabolite Testing for Optimizing Treatment of Inflammatory Bowel Disease Patients
2. Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market
3. Opportunities in Emerging Pharma Markets: Strategies for Optimizing Growth in Key Regions and Therapeutic Areas
4. Reportlinker Adds Commercializing Cancer Vaccines: A Decision Support Tool for Optimizing the Pipeline
5. Health Strategies Group Introduces New One-Stop Suite of Intelligence Services for Optimizing Marketing and Sales Resources in the Institutional Channel
6. Innovative Partnership Helps Improve Medical Research by Optimizing Clinical Trials
7. RadMD Offers Tips on Optimizing Clinical Trial Efficiency
8. At Home Healthcare Expands Telehealth Program With Cardiocom® Telehealth Technology
9. Arena Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference
10. Genomic Health to Present at the JMP Securities Healthcare Conference
11. Uroplasty to Present at the 6th Annual JMP Securities Healthcare Conference
Post Your Comments:
(Date:11/26/2015)... 26, 2015 ... of the  "2016 Future Horizons and ... Drug Monitoring (TDM) Market: Supplier Shares, ... Opportunities"  report to their offering.  ... the addition of the  "2016 Future ...
(Date:11/26/2015)... 26, 2015 Research and Markets ( ... "2016 Future Horizons and Growth Strategies in ... Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities" ... --> --> This new ... Italian therapeutic drug monitoring market, including emerging tests, ...
(Date:11/25/2015)... , Nov. 25, 2015 ... addition of the "Global Brain Monitoring ... offering. --> ) has ... Brain Monitoring Devices Market 2015-2019" report ... and Markets ( ) has announced ...
Breaking Medicine Technology:
(Date:11/27/2015)... Viejo, CA (PRWEB) , ... November 27, 2015 , ... ... for use in Final Cut Pro X. With ProSidebar: Fasion, video editors can ... or use ProSidebar as a minimalist title opener. Utilize presets featuring self-animating drop ...
(Date:11/27/2015)... , ... November 27, 2015 , ... A simply groundbreaking ... is an interesting show that delves into an array of issues that are presently ... could benefit from open dialogue, this show is changing the subjects consumers focus on, ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... ... the largest, most successful and prominent nonprofit healthcare organizations in the country. They ... involvement with various organizations, and helped advance the healthcare industry as a whole ...
(Date:11/26/2015)... ... November 26, 2015 , ... Patients at Serenity Point Recovery, ... together on Thanksgiving Day to share the things that they are most grateful ... Point YouTube channel, patients displayed what they wrote on index cards, describing the ...
(Date:11/26/2015)... ... 2015 , ... The Catalent Applied Drug Delivery Institute today ... dose form selection in early phase drug development. The first of these is ... together the UK’s emerging life sciences companies, corporate partners, and investors, at Milton ...
Breaking Medicine News(10 mins):